Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Brokers Back Star Entertainment Expansion

Apr 04 2018

Star Entertainment will accelerate growth projects, leveraging the Asian customer base of strategic partners Far East Consortium and Chow Tai Fook.


FNArena Corporate Results Monitor

Apr 03 2018

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Large Potential At Cowal For Evolution Mining

Mar 29 2018

Brokers observe Evolution Mining has compelling potential with the expansion of the Cowal gold mine.


Galaxy Flags Strategic Value In Sal De Vida

Mar 27 2018

Galaxy Resources has updated Mt Cattlin estimates and signalled its highly-anticipated Sal de Vida financing/offtake decisions may extend to late 2018.


FNArena Corporate Results Monitor

Mar 27 2018

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Transurban Pays Up In Canada

Mar 26 2018

Transurban will acquire the A25 toll road and bridge in Montreal, in line with its strategy to expand its North American presence.


FNArena Corporate Results Monitor

Mar 26 2018

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Are Synlait Milk’s Implied Returns Excessive?

Mar 26 2018

Synlait Milk is moving towards a higher value packaged product as the industry focus remains on the large Chinese infant formula market.


FNArena Corporate Results Monitor

Mar 23 2018

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Nufarm’s Positive Outlook Gains Momentum

Mar 22 2018

Nufarm is expected to sustain a period of growth from FY19 as recent acquisitions are consolidated and the Omega-3 commercialisation accelerates.



Analyse The Market From A Different Angle